Brain pathology (Zurich, Switzerland) · 2003
Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Graumann Ursula, Reynolds Richard, Steck Andreas J, Schaeren-Wiemers Nicole
Аннотация
Multiple sclerosis is a chronic inflammatory disease of the CNS leading to focal destruction of myelin, still the earliest changes that lead to lesion formation are not known. We have studied the gene-expression pattern of 12 samples of normal appearing white matter from 10 post-mortem MS brains. Microarray analysis revealed upregulation of genes involved in maintenance of cellular homeostasis, and in neural protective mechanisms known to be induced upon ischemic preconditioning. This is best illustrated by the upregulation of the transcription factors such as HIF-1alpha and associated PI3K/Akt signalling pathways, as well as the upregulation of their target genes such as VEGF receptor 1. In addition, a general neuroprotective reaction against oxidative stress is suggested. These molecular changes might reflect an adaptation of cells to the chronic progressive pathophysiology of MS. Alternatively, they might also indicate the activation of neural protective mechanisms allowing preservation of cellular and functional properties of the CNS. Our data introduce novel concepts of the molecular pathogenesis of MS with ischemic preconditioning as a major mechanism for neuroprotection. An increased understanding of the underlying mechanisms may lead to the development of new more specific treatment to protect resident cells and thus minimize progressive oligondendrocyte and axonal loss.
Предметные рубрики MeSH
AgedAged, 80 and overAntigens, CDAntigens, Differentiation, MyelomonocyticAurora KinasesBlotting, NorthernBrainCD3 ComplexCase-Control StudiesDNA-Binding ProteinsFemaleGlial Fibrillary Acidic ProteinHumansHypoxia-Inducible Factor 1, alpha SubunitImmunohistochemistryIn Situ HybridizationMaleMiddle AgedModels, NeurologicalMultiple SclerosisMyelin Basic ProteinMyelin ProteinsMyelin-Associated GlycoproteinMyelin-Oligodendrocyte GlycoproteinNuclear ProteinsOligonucleotide Array Sequence AnalysisPenicillamineProtein Serine-Threonine KinasesRNA, MessengerReverse Transcriptase Polymerase Chain ReactionTranscription FactorsCD68 Molecule